evid
demonstr
human
rhinoviru
hrv
diseas
exclus
limit
upper
airway
may
caus
lower
respiratori
complic
togeth
frequenc
hrv
infect
increas
number
immunocompromis
patient
underlin
need
rapid
accur
diagnosi
hrv
infect
studi
develop
first
quantit
realtim
nucleic
acid
sequencebas
amplif
assay
intern
control
use
molecular
beacon
probe
select
sensit
detect
human
rhinoviru
serotyp
describ
simpl
method
accur
quantifi
rna
target
comput
time
posit
ttp
valu
hrv
rna
quantif
capac
assess
plot
ttp
valu
start
number
target
molecul
use
simpl
method
significantli
increas
diagnost
accuraci
precis
trueness
realtim
nasba
assay
specif
method
verifi
silico
experiment
studi
moreov
assess
clinic
reactiv
assay
nasba
valid
bronchoalveolar
lavag
bal
specimen
quantit
nasba
assay
found
specif
accur
precis
high
repeat
reproduc
human
rhinovirus
hrv
frequent
caus
acut
upper
respiratori
tract
infect
human
usual
respons
case
common
cold
howev
may
also
associ
moresever
lower
respiratori
tract
infect
rhinovirus
isol
case
cystic
fibrosi
otiti
media
sinus
asthma
exacerb
chronic
obstruct
pulmonari
diseas
copd
pneumonia
especi
children
elderli
immunocompromis
patient
evid
demonstr
hrv
diseas
exclus
limit
upper
airway
may
caus
lower
respiratori
complic
togeth
frequenc
hrv
infect
increas
number
immunocompromis
patient
underlin
need
rapid
accur
diagnosi
hrv
infect
two
nucleic
acid
amplif
techniqu
naat
actual
avail
detect
hrv
revers
transcriptionpcr
rtpcr
nucleic
acid
sequencebas
amplif
nasba
nasba
proven
highli
sensit
specif
rapid
rtpcr
techniqu
current
qualit
nasba
kit
detect
hrv
commerci
avail
regist
trademark
own
marci
letoil
franc
quantit
nasba
kit
quantit
molecular
beacon
realtim
nasba
assay
describ
literatur
mainli
identif
human
immunodefici
viru
hiv
respiratori
syncyti
viru
b
influenza
viru
trypanosoma
brucei
aspergillu
fumigatu
plasmodium
speci
listeria
monocytogen
howev
realtim
nasba
assay
use
mathemat
model
analysi
result
requir
employ
specif
complex
softwar
calibr
target
quantit
nasba
assay
instead
comput
ratio
time
posit
ttp
valu
target
rna
intern
control
use
standard
curv
correl
coeffici
less
r
index
insensit
assay
aim
studi
develop
first
quantit
realtim
nucleic
acid
sequencebas
amplif
assay
intern
control
use
molecular
beacon
select
sensit
detect
hrv
serotyp
valid
standard
perform
evalu
diagnost
trueness
precis
accuraci
realtim
nasba
assay
prototyp
human
rhinoviru
serotyp
obtain
american
type
cultur
collect
atcc
manassa
virginia
rhinoviru
serotyp
atcc
origin
isol
human
clinic
specimen
extract
use
automat
extractor
nuclisen
easymag
platform
franc
accord
manufactur
recommend
onehundredmicrolit
use
extract
rna
elut
nucleasefre
water
store
evalu
specif
hrv
nasba
assay
purifi
rna
templat
hrv
isol
select
respiratori
virus
hrv
use
inclus
exclus
test
tabl
vitro
rna
transcript
viral
cdna
gener
first
incub
random
primer
ngll
dntp
mm
invitrogen
rna
min
subsequ
mix
contain
buffer
mm
trishcl
ph
mm
kcl
mm
dtt
mgcl
mm
impromii
rt
ull
recombin
rnasin
ribonucleas
inhibitor
ull
promega
ad
total
volum
reaction
mixtur
incub
min
min
min
use
fast
thermal
cycler
appli
biosystem
monza
itali
crna
product
carri
use
larg
scale
rna
product
system
promega
usa
h
onetenth
crna
product
treat
rnasefre
dnase
promega
usa
min
follow
incub
edta
min
crna
purifi
use
rnagent
kit
promega
usa
follow
manufactur
instruct
crna
quantifi
use
quantit
dna
br
assay
qubit
tm
fluoromet
invitrogen
carlsbad
usa
number
molecul
per
microlit
calcul
molecular
weight
amplicon
mw
avogadro
number
tenfold
dilut
rna
standard
gener
order
amplifi
copi
per
reaction
frozen
use
product
intern
control
ic
rna
use
human
housekeep
gene
encod
protein
present
human
small
nuclear
ribonucleoprotein
snrnp
particl
gener
ic
rna
molecul
extract
clinic
specimen
precis
human
bronchoalveolar
lavag
sampl
subject
revers
transcript
rt
reaction
use
random
primer
ngll
impromii
rt
ull
ic
cdna
product
amplifi
use
adapt
nasba
primer
contain
rna
polymeras
promot
site
briefli
ic
cdna
ad
pcr
solut
contain
flexi
buffer
mm
mgcl
unit
gotaq
hot
start
polymeras
promega
lm
dntp
lm
primer
initi
denatur
step
min
firstround
pcr
amplif
carri
follow
condit
cycl
one
cycl
min
use
fast
thermal
cycler
appli
biosystem
pcr
product
transcrib
vitro
use
previous
describ
see
vitro
transcript
materi
method
section
tenfold
dilut
ic
rna
standard
gener
order
amplifi
copi
per
reaction
primer
molecular
beacon
probe
obtain
literatur
tabl
synthes
eurogentec
sera
belgium
dilut
final
concentr
lmoll
moreov
maxim
oligonucleotid
stabil
ad
dimethyl
sulfoxid
dmso
primer
beacon
mixtur
hrv
beacon
label
fam
end
quencher
dabcyl
end
ic
beacon
contain
rox
end
dabcyl
quencher
end
stabil
predict
structur
beacon
analyz
use
european
mfold
server
http
frontend
realtim
nasba
reaction
perform
nuclisen
easyq
analyz
use
nuclisen
easyq
basic
kit
version
lyon
franc
amplif
accord
manufactur
manual
obtain
best
amplif
effici
condit
realtim
nasba
assay
optim
best
primer
beacon
kcl
concentr
determin
titrat
ic
rna
copi
hrv
rna
perform
determin
optim
amount
intern
control
gener
greatest
dynam
rang
assay
without
interfer
detect
hrv
rna
data
shown
result
reaction
run
addit
copi
ic
rna
briefli
total
volum
reaction
mixtur
contain
mm
kcl
lm
hrvand
icspecif
primer
incub
hrv
rna
ic
rna
presenc
lm
hrvand
icmolecular
beacon
min
denatur
secondari
structur
rna
reaction
subsequ
cool
min
anneal
primer
ad
enzym
mixtur
contain
avian
myeloblastosi
viru
retrotranscriptas
rnase
h
rna
polymeras
brief
centrifug
gentl
mix
tap
tube
incub
min
estim
dynam
rang
realtim
nasba
assay
rang
concentr
method
perform
linear
manner
accept
level
trueness
precis
use
hrv
standard
dilut
copiesl
copyl
sensit
nasba
assay
determin
lowest
standard
dilut
consist
detect
replic
reaction
frequenc
wherea
limit
detect
lowest
concentr
target
quantifi
nucleasefre
water
includ
notempl
control
ntc
serv
control
background
fluoresc
optim
realtim
nasba
assay
condit
allow
effici
amplif
hrv
target
establish
sensit
limit
detect
nasba
assay
assess
repeat
test
serial
logarithm
dilut
hrv
rna
standard
rang
copi
reaction
particular
hrv
nasba
dynam
rang
calcul
ttp
valu
time
point
emit
fluoresc
exce
baselin
emiss
regress
standard
curv
use
excel
spreadsheet
creat
ad
hoc
us
tabl
result
linear
regress
show
hrv
realtim
nasba
assay
abl
quantifi
copiesreact
standard
curv
hrv
dilut
plot
versu
nasba
amplif
express
tpp
shown
fig
wherea
plot
amplif
hrv
standard
dilut
copiesreact
optim
amount
ic
rna
copiesreact
shown
fig
consist
replic
measur
correl
coeffici
r
indic
linear
tpp
valu
plot
standard
curv
r
index
hrv
sensit
realtim
nasba
assay
determin
lowest
standard
dilut
consist
detect
replic
reaction
frequenc
hrv
sensit
copiesreact
wherea
limit
detect
reliabl
quantif
copi
reaction
base
data
avail
blast
align
softwar
primer
test
silico
potenti
crossreact
respiratori
virus
hrv
demonstr
signific
homolog
sequenc
moreov
hrv
primer
probe
set
test
respiratori
virus
abl
detect
hrv
isol
thu
inclus
tabl
assay
specif
demonstr
abil
exclud
respiratori
virus
hrv
list
tabl
posit
result
demonstr
respiratori
virus
indic
molecular
assay
highli
specif
hrv
isol
thu
exclus
tabl
diagnost
trueness
hrv
realtim
nasba
method
defin
degre
agreement
averag
valu
obtain
larg
seri
test
result
accept
refer
valu
evalu
establish
level
trueness
concord
assign
valu
data
replic
measur
dilut
perform
analyz
use
student
test
compar
mean
concentr
dilut
accept
refer
valu
mean
concentr
dilut
method
shown
tabl
test
result
indic
signific
differ
experiment
mean
assign
valu
analysi
statist
show
method
tcalc
valu
lower
ttab
valu
demonstr
signific
trueness
hrv
assay
precis
method
express
coeffici
variat
cv
log
valu
concentr
repeat
intermedi
reproduc
hrv
assay
evalu
differ
concentr
rang
copiesreact
replic
measur
n
refer
viral
quantif
standard
within
singl
run
differ
run
experi
perform
three
differ
oper
precis
associ
dilut
measur
assess
calcul
cv
cv
within
singl
run
repeat
rang
wherea
cv
differ
run
intermedi
reproduc
rang
tabl
indic
precis
assay
satisfactori
diagnost
accuraci
includ
trueness
precis
measur
accuraci
usual
express
numer
term
bia
lack
agreement
accuraci
shall
within
accept
refer
valu
whole
dynam
rang
accord
document
iso
data
percentag
inaccuraci
hrv
method
report
tabl
develop
realtim
nasba
assay
abl
detect
hrv
rna
bal
specimen
ttp
valu
nasbaposit
sampl
rang
min
plot
standard
curv
fig
data
shown
result
valid
addit
intern
control
rna
rule
inhibit
amplif
case
amplif
control
rna
observ
thu
confirm
neg
posit
result
valid
moreov
neg
control
reaction
nasba
neg
demonstr
absenc
amplicon
contamin
viral
respiratori
tract
infect
recogn
predomin
caus
human
diseas
improv
clinic
manag
patient
import
obtain
accur
diagnosi
identifi
caus
agent
earli
infect
ensur
appropri
treatment
studi
develop
first
quantit
nasba
assay
detect
hrv
serotyp
combin
nasba
amplif
molecular
beacon
probe
assay
becom
realtim
analysi
tool
offer
faster
result
convent
rtpcr
techniqu
sinc
nasba
amplif
involv
three
separ
enzym
kinet
paramet
variabl
everi
measur
inevit
weusten
et
al
first
describ
mathemat
model
rna
amplif
target
intern
calibr
rna
molecular
beaconbas
nasba
reaction
normal
enzym
effici
differ
reaction
howev
descript
model
includ
essenti
paramet
need
oper
model
consequ
analysi
use
model
requir
softwar
calibr
target
commerci
avail
specif
target
describ
altern
method
normal
nasba
data
use
simpl
tpp
calcul
presenc
intern
control
reduc
variabl
replic
increas
precis
trueness
accuraci
predict
unknown
concentr
hrv
rna
shown
tube
tube
variat
within
nasba
normal
addit
intern
control
reaction
particular
optim
concentr
intern
calibr
determin
concentr
provid
greatest
dynam
rang
amplif
target
intern
control
rna
studi
fix
amount
copi
intern
calibr
rna
optim
assay
report
data
shown
furthermor
addit
intern
control
fundament
identifi
fals
neg
result
reaction
failur
monitor
effect
unknown
sampl
factor
might
interfer
amplif
kinet
concern
import
primer
kcl
nasba
optim
role
emphas
date
nasba
isotherm
nucleic
acid
amplif
method
abl
specif
amplifi
target
rna
use
specif
primer
kcl
background
initi
concentr
primer
rel
total
concentr
amplifi
rna
high
rate
limit
rel
small
amount
primer
consum
deplet
initi
present
pool
rna
copi
linear
phase
nasba
process
time
point
obvious
primer
concentr
becom
rate
limit
declin
practic
zero
time
point
dna
intermedi
level
reach
maximum
rna
product
proce
high
speed
reaction
proceed
rna
polymerasemedi
format
rna
dna
intermedi
templat
time
interv
repres
second
phase
nasba
process
character
exponenti
kinet
observ
high
concentr
primer
kcl
elong
linear
phase
nasba
process
short
exponenti
amplif
wherea
low
concentr
primer
kcl
promot
exponenti
phase
particular
studi
use
rel
low
concentr
primer
kcl
lm
mm
respect
elong
exponenti
phase
nasba
process
accordingli
minim
reactiontoreact
variat
use
simpl
expedi
significantli
increas
accuraci
precis
trueness
predict
standard
ttp
calcul
summari
describ
simplifi
method
calcul
unknown
concentr
target
rna
use
intern
calibr
method
allow
greater
precis
accuraci
trueness
predict
hrv
rna
standard
ttp
analysi
conclus
describ
first
realtim
nasba
assay
capabl
accur
quantif
hrv
rna
make
valuabl
tool
molecular
diagnost
hrv
serotyp
